← Back

Wire · operational-macro

Neurology Trial Sites Take 167 Days to Activate, Delaying Enrollment

Published

11 October 2026

Topic

operational-macro

◆ Sectors

BiotechDrug DiscoveryMedtech

◆ Geography

United States

◆ Source

Read at clinicaltrialvanguard.com →

◆ Verified

Fusion42 · 11 October 2026 · Fusion42 review

Neurology clinical trial sites now take an average of 167 days to activate, significantly longer than the industry target of 90 to 120 days, causing costly delays and lost patient enrollment. The main barriers include budget negotiations, contract finalisation, and delayed rater certification, resulting in sites being 'active' on paper but unable to enrol patients.

This Wire brief sits within Fusion42's coverage of Biotech, Drug Discovery and Medtech.

◆ ◆ The Wire takeaway

You must realign your clinical trial timelines around actual rater certification dates, not site activation paperwork; slipping activation by months kills your patient pipeline and inflates costs. Budget and contract delays in neurology trials create a waiting game you need to break immediately or risk long, costly enrollment gaps.

◆ Coverage

1 source · 11 Oct 2026

◆ Related on Wire

◆ Topics

BiotechDrug DiscoveryMedtechclinical-trialsneurologypatient-enrollmentactivation-delaytrial-operations